Cytokinetics (Switzerland) GmbH

For 25 years, Cytokinetics has been developing potential drugs to improve the healthspan of people with serious cardiovascular and neuromuscular diseases associated with impaired muscle function. As a pioneer in the field of muscle biology and muscle mechanics, we have developed a broad and diverse pipeline of cardiovascular and neuromuscular drugs that target muscle and have the potential to improve muscle function in diseases with impaired contractility.